Background The systemic immune-inflammation index (SII) is a novel biomarker to predict
the prognosis of some malignant tumors based on neutrophil, platelet, and lymphocyte …

The systemic immune-inflammation index (SII) is a significant prognostic factor in some
cancer types. However, the prognostic role of SII in cancer patients with immunotherapy …

Systemic inflammation indices were found to be correlated with therapeutic outcome in
several cancers. This study retrospectively analyzes the predictive role of a broad range of …

Objective The objective of this research was to analyze the prognostic significance of the
minimum count of lymphocytes (LY) and the corresponding ratio of neutrophil‐to …

Background Abnormal changes in body composition and systemic inflammation response
have been associated with poor survival of cancer patients. Our study was to explore the …

Objectives: The present study aimed to identify the predictive value of inflammatory indexes
stratified according to human papillomavirus (HPV) infection status in women with FIGO …

Introduction The influence of systemic inflammatory markers on early-stage cervical cancer
(ECC) patients is contradictory. No previous study analyzed whether these markers may be …

Simple Summary We explored whether specific factors, like inflammation indicators in the
blood, could help predict treatment outcomes for locally advanced cervical cancer (LACC) …

Purpose The platelet-to-lymphocyte ratio (PLR) is considered correlated with cancer
prognosis including cervical cancer, in addition to high-risk papillomavirus (HR-HPV) …

Rationale and Objectives To investigate the value of machine learning-based radiomics,
intravoxel incoherent motion (IVIM) diffusion-weighted imaging and its combined model in …